Note

Thank you very much for your interest in our website.

Since 01/12/16 Microsoft no longer provides security updates or technical support for old versions of Internet Explorer. Regular security updates contribute to the protection.

https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support

We recommend that you update your browser to view our website in full, e.g. with Google Chrome, Mozilla Firefox or Apple Safari.

If you would like to continue using Internet Explorer, please note that the content may not be displayed correctly due to lack of support.

Thank you for your understanding,
Your MainFirst Team

Verstanden, Seite trotzdem benutzen
False
Print

MainFirst übernimmt das europäische institutionelle Aktien-Geschäft von Raymond James

09.10.2018

Die MainFirst Bank AG, eines der führenden unabhängigen, europäischen Aktienresearch- und -handelshäuser, übernimmt zum 1. Dezember 2018 das institutionelle Brokerage-Geschäft in europäischen Aktien von Raymond James in Paris und London. Im Zuge dessen übernimmt MainFirst aus den Bereichen Research, Sales und Sales Trading auch die 29 Mitarbeiter von Raymond James in Paris und sechs weitere Analysten in London, die in die Organisation von MainFirst integriert werden. Mit der Akquisition stärkt MainFirst seine strategische Position, insbesondere in Frankreich.

"Darüber hinaus haben wir uns zu diesem Schritt entschlossen, um Skaleneffekte zu erreichen, unsere Wettbewerbsvorteile in der neuen MiFiD II-Welt besser zu nutzen und unsere Kunden auf Basis einer verbreiterten Plattform bedienen zu können", sagt Ebrahim Attarzadeh, Vorstand bei der MainFirst Bank AG. Durch die Übernahme wächst die Zahl der gecoverten europäischen Aktien bei MainFirst um rund ein Viertel auf 400 - zugleich steigert MainFirst die Zahl seiner institutionellen Kunden in Frankreich.

Go to Newsroom

Please select your profile

The information and content on this website do not represent a public offer or an invitation to submit an offer for the acquisition of securities, fund units or financial instruments. An investment decision concerning the products represented here should be made solely on the basis of the relevant sales documentation (prospectus, Key Investor Information Document, semi-annual and annual reports) and under no circumstances on the basis of this website. The products described on this website may not be offered for sale in all countries and are in any case reserved for the group of investors entitled to purchase the products. The information and content on this website are therefore not aimed at natural persons or legal entities whose residence or registered office is subject to legislation that imposes restrictions on the dissemination of such information. Natural persons or legal entities whose residence or registered office is subject to foreign legislation should obtain information about the restrictions in question and take them into account accordingly. In particular, the information contained on this website is not intended for the USA. US citizens as defined in Regulation S of the US Securities Act of 1933 and legal entities based in the USA shall be prohibited from accessing this website. Nor may information provided on this website be disseminated or transmitted in the USA. The products listed here are not, and shall not be, registered under the US Securities Act of 1933; authorisation for trading in these products pursuant to the US Commodities Exchange of Act 1936 has not been obtained. The products may not be sold or offered in the USA, to US citizens or to legal entities based in the USA.

Select